Intercept Announces Positive Data in Fibrosis due to NASH from a New Analysis of its Phase 3 REGENERATE Study of Obeticholic Acid (OCA)

3 years ago

OCA 25 mg met the agreed primary endpoint of improvement in liver fibrosis without worsening of NASH at 18 months…

Clearside Biomedical Suprachoroidal Delivery Technology to be Featured at Upcoming ASRS and OIS Medical Meetings

3 years ago

- Multiple Podium and Poster Presentations on XIPERE® and Gene Therapy Delivery Utilizing SCS Microinjector® - ALPHARETTA, Ga., July 07,…

Arcoma Precision i5 approved for sales in Singapore

3 years ago

2022-07-07 PRESSRELEASE Arcoma Precision i5 approved for sales in Singapore Arcoma has many installations in Singapore and we are, together…

Amryt Presents New Analyses from the EASE Phase 3 Trial in Epidermolysis Bullosa at SPD 2022

3 years ago

Amryt Presents New Analyses from the EASE Phase 3 Trial in Epidermolysis Bullosa at SPD 2022 - Key highlights include…

Algernon Pharmaceuticals Provides Update on Its Phase 1 DMT Stroke Study

3 years ago

VANCOUVER, British Columbia, July 07, 2022 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB:…

TScan Therapeutics Appoints Debora Barton, M.D., as Chief Medical Officer

3 years ago

Debora Barton Debora BartonWALTHAM, Mass., July 07, 2022 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biopharmaceutical company…

XORTX Announces Pre-Phase 3 Meeting Request with US Food and Drug Administration (FDA)

3 years ago

CALGARY, Alberta, July 07, 2022 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX…

Eliem Therapeutics to Host Virtual Investor Event on July 21, 2022

3 years ago

SEATTLE and CAMBRIDGE, United Kingdom, July 07, 2022 (GLOBE NEWSWIRE) -- Eliem Therapeutics, Inc. (Nasdaq: ELYM), a clinical-stage biotechnology company…

BioAdaptives, Inc. Introduces PrimiSleep™, An Advanced Sleep-Aid Designed to Harmonize with the Body’s Unique Circadian Rhythm, Delivering Gentle, Sustained, Restorative Sleep With No “Hangover”

3 years ago

PrimiSleep™ Enters Rapidly Growing Global Sleep Aid Market With State-of-the-Art Supplement LAS VEGAS, NV, July 07, 2022 (GLOBE NEWSWIRE) --…

EvolveImmune Therapeutics Appoints Jay Fine, Ph.D., as President of Research and Development

3 years ago

Over 30 Years of Leadership in Drug Discovery and Development, Translational Sciences and Biomarker Research in Immunology, Inflammatory Diseases and…